Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model

详细信息    查看全文

• 作者：Emanuele Ricci (1)
  Graziella Vanosi (2)
  Andrea Lindenmair (3) (4)
  Simone Hennerbichler (4)
  Anja Peterbauer-Scherb (4)
  Susanne Wolbank (3)
  Anna Cargnoni (1)
  Patrizia Bonassi Signoroni (1)
  Marino Campagnol (5)
  Christian Gabriel (4)
  Heinz Redl (3)
  Ornella Parolini (1)
  
• 关键词：Human amniotic membrane ; Cryopreservation ; Bile duct ligation ; Liver fibrosis ; Collagen content ; Digital image analysis
• 刊名：Cell and Tissue Banking
• 出版年：2013
• 出版时间：September 2013
• 年：2013
• 卷：14
• 期：3
• 页码：475-488
• 全文大小：775KB
• 参考文献：1. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209鈥?18
  2. Baum J (2002) Thygeson lecture. Amniotic membrane transplantation: why is it effective? Cornea 21:339鈥?41 CrossRef
  3. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, Housset C (2007) Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87:292鈥?03 CrossRef
  4. Beck PL, Lee SS (1995) Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis. J Hepatol 23:235 CrossRef
  5. Benirschke K, Kaufmann P (2000) Pathology of human placenta. Springer, New York CrossRef
  6. Branski LK, Herndon DN, Celis MM, Norbury WB, Masters OE, Jeschke MG (2008) Amnion in the treatment of pediatric partial-thickness facial burns. Burns 34:393鈥?99 CrossRef
  7. Burman S, Tejwani S, Vemuganti GK, Gopinathan U, Sangwan VS (2004) Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank 5:161鈥?75 CrossRef
  8. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, Albertini A, Parolini O (2009) Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant 18:1147鈥?159 CrossRef
  9. Chen YT, Li W, Hayashida Y, He H, Chen SY, Tseng DY, Kheirkhah A, Tseng SC (2007) Human amniotic epithelial cells as novel feeder layers for promoting ex vivo expansion of limbal epithelial progenitor cells. Stem Cells 25:1995鈥?005 CrossRef
  10. Davis JS (1909) II. Skin grafting at the Johns Hopkins hospital. Ann Surg 50:542鈥?49 CrossRef
  11. Diaz-Prado S, Muinos-Lopez E, Hermida-Gomez T, Cicione C, Rendal-Vazquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ (2011) Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation 81:162鈥?71 CrossRef
  12. Dranoff JA, Wells RG (2010) Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51:1438鈥?444 CrossRef
  13. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouliere A (2006) Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 38:135鈥?51
  14. Hennerbichler S, Reichl B, Pleiner D, Gabriel C, Eibl J, Redl H (2007) The influence of various storage conditions on cell viability in amniotic membrane. Cell Tissue Bank 8:1鈥? CrossRef
  15. Hermans MH (2011) Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns 37:873鈥?81 CrossRef
  16. Kesting MR, Wolff KD, Mucke T, Demtroeder C, Kreutzer K, Schulte M, Jacobsen F, Hirsch T, Loeffelbein DJ, Steinstraesser L (2009) A bioartificial surgical patch from multilayered human amniotic membrane-In vivo investigations in a rat model. J Biomed Mater Res B Appl Biomater 90:930鈥?38
  17. Kruse FE, Joussen AM, Rohrschneider K, You L, Sinn B, Baumann J, Volcker HE (2000) Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol 238:68鈥?5 CrossRef
  18. Kubo M, Sonoda Y, Muramatsu R, Usui M (2001) Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 42:1539鈥?546
  19. Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC (2000) Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res 20:325鈥?34 CrossRef
  20. Liu J, Sheha H, Fu Y, Liang L, Tseng SC (2010) Update on amniotic membrane transplantation. Expert Rev Ophthalmol 5:645鈥?61 CrossRef
  21. Lo V, Pope E (2009) Amniotic membrane use in dermatology. Int J Dermatol 48:935鈥?40 CrossRef
  22. Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW (2009) Angiotensin-(1鈥?), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci 117:375鈥?86 CrossRef
  23. Magatti M, De Munari S, Vertua E, Gibelli L, Wengler GS, Parolini O (2008) Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182鈥?92 CrossRef
  24. Manuelpillai U, Moodley Y, Borlongan CV, Parolini O (2011) Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 32(Suppl 4):S320鈥揝325 CrossRef
  25. Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP (2011) Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int 108:243鈥?48
  26. Moon JH, Lee JR, Jee BC, Suh CS, Kim SH, Lim HJ, Kim HK (2008) Successful vitrification of human amnion-derived mesenchymal stem cells. Hum Reprod 23:1760鈥?770 CrossRef
  27. Mucke T, Loeffelbein DJ, Holzle F, Slotta-Huspenina J, Borgmann A, Kanatas AN, Mitchell DA, Wagenpfeil S, Wolff KD, Kesting MR (2010) Intraoral defect coverage with prelaminated epigastric fat flaps with human amniotic membrane in rats. J Biomed Mater Res B Appl Biomater 95:466鈥?74
  28. Nakamura T, Yoshitani M, Rigby H, Fullwood NJ, Ito W, Inatomi T, Sotozono C, Shimizu Y, Kinoshita S (2004) Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci 45:93鈥?9 CrossRef
  29. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM (2008) Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 15:88鈥?9
  30. Ogbureke KU, Fisher LW (2007) SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity. J Histochem Cytochem 55:403鈥?09 CrossRef
  31. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26:300鈥?11 CrossRef
  32. Penz-Osterreicher M, Osterreicher CH, Trauner M (2011) Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol 25:245鈥?58 CrossRef
  33. Petter-Puchner AH, Fortelny RH, Mika K, Hennerbichler S, Redl H, Gabriel C (2011) Human vital amniotic membrane reduces adhesions in experimental intraperitoneal onlay mesh repair. Surg Endosc 25:2125鈥?131 CrossRef
  34. Popov Y, Schuppan D (2009) Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50:1294鈥?306 CrossRef
  35. Ramadori G, Saile B (2004) Portal tract fibrogenesis in the liver. Lab Invest 84:153鈥?59 CrossRef
  36. Rodriguez-Ares MT, Lopez-Valladares MJ, Tourino R, Vieites B, Gude F, Silva MT, Couceiro J (2009) Effects of lyophilization on human amniotic membrane. Acta Ophthalmol 87:396鈥?03 CrossRef
  37. Roskams T, Desmet V (1998) Ductular reaction and its diagnostic significance. Semin Diagn Pathol 15:259鈥?69
  38. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, Kobayashi M, Yokoyama Y (2004) Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 78:208鈥?14 CrossRef
  39. Sant鈥橝nna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O (2011) Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant 20:441鈥?53 CrossRef
  40. Sippel KC, Ma JJ, Foster CS (2001) Amniotic membrane surgery. Curr Opin Ophthalmol 12:269鈥?81 CrossRef
  41. Snowdon VK, Fallowfield JA (2011) Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res 35:794鈥?99 CrossRef
  42. Starkel P, Leclercq IA (2011) Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol 25:319鈥?33 CrossRef
  43. Tao H, Fan H (2009) Implantation of amniotic membrane to reduce postlaminectomy epidural adhesions. Eur Spine J 18:1202鈥?212 CrossRef
  44. Turkay C, Yonem O, Arici S, Koyuncu A, Kanbay M (2008) Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci 53:789鈥?93 CrossRef
  45. Wells RG (2008) Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12:759鈥?68 (viii) CrossRef
  46. Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A (2010) Alternative sources of adult stem cells: human amniotic membrane. Adv Biochem Eng Biotechnol 123:1鈥?7
  
• 作者单位：Emanuele Ricci (1)
  Graziella Vanosi (2)
  Andrea Lindenmair (3) (4)
  Simone Hennerbichler (4)
  Anja Peterbauer-Scherb (4)
  Susanne Wolbank (3)
  Anna Cargnoni (1)
  Patrizia Bonassi Signoroni (1)
  Marino Campagnol (5)
  Christian Gabriel (4)
  Heinz Redl (3)
  Ornella Parolini (1)
  
  1. Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Via Bissolati 57, 25124, Brescia, Italy
  2. Dipartimento di Scienze Cliniche Veterinarie-Sezione di Radiologia Clinica e Sperimentale, Facolt脿 di Medicina Veterinaria, Universit脿 degli Studi di Milano, 20133, Milan, Italy
  3. Ludwig Boltzmann Institute for Experimental and Clinical Traumatology/AUVA Research Centre, Austrian Cluster for Tissue Regeneration, 1200, Vienna, Austria
  4. Red Cross Blood Transfusion Service of Upper Austria, Austrian Cluster for Tissue Regeneration, 4017, Linz, Austria
  5. Facolt脿 di Medicina Veterinaria, Central Animal Facility, Universit脿 degli Studi di Milano, 20133, Milan, Italy
  

文摘

The human amniotic membrane (hAM), thanks to its favorable properties, including anti-inflammatory, anti-fibrotic and pro-regenerative effects, is a well-known surgical material for many clinical applications, when used both freshly after isolation and after preservation. We have shown previously that hAM patching is a potential approach to counteract liver fibrosis. Indeed, when fresh hAM was used to cover the liver surface of rats with liver fibrosis induced by the bile duct ligation (BDL) procedure, the progression and severity of fibrosis were significantly reduced. Since cryopreservation enables safety and long-term storage of hAM but may influence its functional properties, here we compared the anti-fibrotic effects of fresh and cryopreserved hAM in rats with BDL-induced liver fibrosis. After BDL, the rat liver was covered with a piece of fresh or cryopreserved hAM, or left untreated. Six weeks later, the degree of liver fibrosis was assessed histologically using the Knodell and the METAVIR scoring systems. Digital image analysis was used to quantify the percentage of the areas of each liver section displaying ductular reaction, extracellular matrix (ECM) deposition, activated myofibroblasts and hepatic stellate cells (HSCs). Liver collagen content was also determined by spectrophotometric technique. The degree of liver fibrosis, ductular reaction, ECM deposition, and the number of activated myofibroblasts and HSCs were all significantly reduced in hAM-treated rats compared to control animals. Fresh and cryopreserved hAM produced the same anti-fibrotic effects. These findings indicate that cryopreservation maintains the anti-fibrotic properties of hAM when used as a patch to reduce the severity of liver fibrosis.